 RedHill Biopharmas Talicia added to Medi-Cal Contract Drug List with No Prior Authorization Requirements Addition of Talicia by Medi-Cal Fee-For-Service FFS Contract Drug List CDL with no prior authorization is an important expansion of coverage for California patients and continues to increase Talicias overall unrestricted coverage Coverage commenced for two million patients in Medi-Cals FFS plan on October 1st, 2021 Talicia is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. 